You are here

Article Text

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Macitentan in the treatment of severe digital ulcers
  1. Tatiana Gonçalves1,2 and
  2. Lèlita Santos1,2,3
  1. 1 Internal Medicine Service, Coimbra Hospital and University Centre, Coimbra, Portugal
  2. 2 Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  3. 3 CIMAGO Research Centre, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  1. Correspondence to Dr Tatiana Gonçalves, tatianafgoncalves90{at}gmail.com

Abstract

Digital ulcers are one of the earliest and most disabling manifestations of systemic sclerosis (SSc). We report the clinical case of a female patient with SSc and severe digital ulcers, recurrent and refractory to the classic treatments to whom it was prescribed off-label macitentan with complete resolution of the condition.

  • musculoskeletal and joint disorders
  • skin
  • therapeutic indications
  • connective tissue disease
  • musculoskeletal syndromes

https://doi.org/10.1136/bcr-2018-228295

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors TG wrote the article and followed the patient’s case. LS corrected the case, interpreted the data and also followed the patient afterwards.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Patient consent for publication Obtained.